Market Scope & Overview
The Anxiety Disorder Treatment Market is experiencing significant growth, driven by the increasing prevalence of anxiety disorders globally and the rising awareness about mental health. Innovations in pharmaceuticals, such as the development of novel anxiolytic drugs and personalized medicine approaches, are enhancing treatment efficacy and patient outcomes. Additionally, advancements in non-pharmacological therapies, including cognitive-behavioral therapy (CBT), mindfulness-based stress reduction (MBSR), and digital therapeutics, are broadening the spectrum of available treatments. The market is also witnessing a surge in telemedicine platforms, providing greater accessibility to mental health care